DOI:
10.1039/D5CC01179E
(Communication)
Chem. Commun., 2025,
61, 7297-7300
Bidentate (P^N) Au(III)–azide complexes: synthesis and reductive elimination studies†
Received
4th March 2025
, Accepted 14th April 2025
First published on 14th April 2025
Abstract
Herein, we report the synthesis and characterization of novel (P^N) aryl Au(III)–azide complexes. The reductive elimination from these Au(III) complexes to forge C(sp2)–N3 bonds has also been demonstrated. Considering the feasibility of C(sp2)–N3 reductive elimination in Au(III)–azide complexes, the gold-catalyzed C(sp2)–N3 cross-coupling reaction has been achieved. Furthermore, it is shown that the Au(III)–azide complexes undergo facile azide exchange with cyano and alkyne nucleophiles, facilitating C(sp2)–C(sp) cross-coupling.
Gold(III) complexes are of significant interest due to their redox activity and potential applications in catalysis,1 medicinal chemistry2 and materials science.3 In recent years, Au(III) complexes have been largely explored as key intermediates in gold-catalyzed cross-coupling reactions. Due to the high redox potential of the Au(I)/Au(III) redox couple, the Au(III) complexes are prone to undergo reduction to Au(I) (E0red Au(III)/Au(I) = +1.41 V vs. SHE) or Au(0) (E0red Au(III)/Au(0) = + 1.52 V vs. SHE).4 This tendency renders the synthesis of stable Au(III) complexes difficult.
Traditionally, chelating bidentate and pincer tridentate ligands play a crucial role in stabilizing Au(III) complexes by modulating redox potentials (Scheme 1a).5 Bidentate (C^N) ligands have been widely employed for the synthesis of stable Au(III) complexes, with their properties and catalytic performance thoroughly investigated.6 In recent years, the bidentate (P^N) ligands have emerged as powerful ligands for enabling redox gold catalysis.7 Such bidentate (P^N) ligands also proved to be effective in stabilizing the resultant Au(III) complexes enabling their isolation, characterization and their further catalytic applications. For instance, the group of Maynard and Spokoyny utilized (P^N) ligands to develop organometallic Au(III) bioconjugation reagents for the chemoselective cysteine arylation of unprotected peptides and proteins.8 Furthermore, Houk, Maynard and Spokoyny demonstrated the application of a hemilabile (P^N) ligand “MeDalPhos” in achieving the ultrafast organometallic abiotic cysteine bioconjugation.9 In 2021, Nevado and co-workers reported the synthesis of DalPhos based (P^N) aryl Au(III) fluoride complexes and explored their reactivity in transmetalation reactions (Scheme 1b).10 Subsequently, in 2024, Bourissou and co-workers reported the synthesis of (P^N) aryl Au(III) fluorides via ligand-enabled oxidative fluorination of Au(I) and demonstrated their reductive elimination to obtain aryl fluorides (Scheme 1c).11
 |
| Scheme 1 Gold(III) complexes – literature background and present work. | |
The oxidative addition of Au(I) has long been considered the key challenge, driving the design and development of various ligands to facilitate the oxidation process.12 In contrast, due to the limited number of stable Au(III) complexes, the study of reductive elimination from Au(III) remains relatively underexplored. Clearly, the stability of gold(III) complexes depends on the ligand system and the nature of the donor atoms.5 We envisioned that azide being a nucleophilic ligand could effectively stabilize the (P^N) ligated gold(III) intermediates. The early report on an Au(III)–azide complex by Uson and co-workers involved the synthesis of [(N3)Au(C6F5)2PPh3] from the [O3ClOAu(C6F5)2PPh3] precursor.13 Later, Gade and co-workers synthesized an (N^N^N)Au(III)–azide complex featuring a bis(2-pyridylimino)isoindolato (BPI) ligand.14 Recently, Au(III)-azide complexes such as [PPh4][(CF3)3Au(N3)],15trans-[AuF2(N3)(SIMes)],16 and [Au(N3)(dpb)]17 (dpb = 1,3-di(2-pyridyl)phenide) were isolated and characterized. Additionally, bis, tris, and tetra-azido gold(III) complexes have been reported.18 Interestingly, the reactivity of the Au(III)–azide complexes has never been reported. Motivated by the exceptional activity of bidentate (P^N) ligands,7 we envisaged that the (P^N) ligand could provide access to stable Au(III)–azide complexes. Here, we present the synthesis and characterization of (P^N) aryl Au(III)–azide complexes, along with their reductive elimination studies to forge C(sp2)–N3 bonds (Scheme 1d). Based on the gathered knowledge, we have also shown the feasibility of obtaining azidoarenes from a ligand-enabled gold-catalyzed C(sp2)–N3 cross-coupling reaction. Furthermore, we showed that the (P^N) aryl Au(III)–azide complexes can undergo facile ligand exchange followed by reductive elimination to forge a C(sp2)–C(sp) bond.
At first, the synthesis of (P^N) ligated Au(III)–azide complexes was achieved by following a two-step procedure (Scheme 2). Firstly, the (P^N) gold chloride 1 was treated with aryl iodides in the presence of AgSbF6 in dichloromethane at room temperature to generate the aryl Au(III) complex 2. This complex was further treated with AgSbF6 and sodium azide to obtain the aryl Au(III)–azide complex 3. Crystals could be obtained by vapor diffusion of n-hexane into a concentrated CH2Cl2 solution of the gold complex 3a at room temperature. The structure of 3a was unambiguously confirmed by NMR spectroscopy and X-ray diffraction analysis. The Au(III)–azide complex 3a features a square planar geometry with the azide group positioned trans to the phosphine ligand. The bond length of the Au–N bond trans to the phosphorus atom is 2.052 Å and that of the Au–C bond trans to the nitrogen atom is 1.965 Å. The terminal N–N bond length (1.121 Å) is shorter than the internal N–N bond length (1.187 Å), which is consistent with the bond length values observed for the (C^N) cyclometalated Au(III)–diazide complex.18e The C–Au–N bond angle in 3a is 89.995° as determined from the X-ray structure. As shown in Scheme 2, (P^N) ligated aryl Au(III)–azide complexes bearing various electron-rich (–Me and –OMe), electron-deficient (–COMe, –CO2Me, and –CF3) and halogen groups (–F and –Cl) at the ortho, meta and para positions (3a–3i) were synthesized in good to excellent yields (81–95%). Notably, the Au(III)–azide complexes demonstrated remarkable stability, regardless of the electronic nature of the aryl group at the Au(III) center.
 |
| Scheme 2 Synthesis of (P^N) ligated Au(III)–azide complexes.a a Reaction conditions: (a) 0.20 mmol 1, 0.40 mmol Ar–I, 1 equiv. AgSbF6, DCM, rt, 1 h. (b) 1 equiv. AgSbF6, 2 equiv. NaN3, DCM, rt, 1 h. b Isolated yields. c Ellipsoids are shown at 50% probability level. | |
With Au(III)–azide complexes in hand, we sought to explore their reactivity towards transmetalation and reductive elimination processes. We initially investigated the C(sp2)–N3 reductive elimination under thermal conditions (Scheme 3a). To our delight, when complex 3a was subjected to heating at 100 °C, the C(sp2)–N3 reductive elimination occurred to deliver the aryl azide 4a in 96% yield. Similarly, the gold(III)–azide complexes (3a–3f, and 3h) were found to undergo reductive elimination to afford the corresponding aryl azides in excellent yields (90–96%) (Scheme 3a).
 |
| Scheme 3 (a) C(sp2)–N3 reductive elimination from (P^N) aryl Au(III)–azide complexes.a a Conditions: 0.40 mmol 3, DCE (0.1 M), 100 °C, 12 h. (b) Gold-catalyzed aryl-N3 cross-coupling reaction.b b Conditions: 0.2 mmol iodoarene, 0.2 mmol TMSN3, 5 mol% MeDalPhosAuCl, 10 mol% AgSbF6, 1.1 equiv. AgOAc, DCE : DMSO (10 : 1), 100 °C, 24 h. c Isolated yields. | |
Owing to the potential of (P^N) ligands in facilitating several C–C,19 C–N,20 C–O21 and C–S/Se22 cross-coupling reactions, we investigated the gold-catalyzed aryl-N3 cross-coupling reaction.23 Motivated by the successful reductive elimination of C(sp2)–N3 under stoichiometric conditions, we performed the reaction of iodobenzene with NaN3 in the presence of 5 mol% MeDalPhosAuCl, 1.1 equiv. of AgOAc and 10 mol% AgSbF6 in DCE
:
DMSO (10
:
1) at 100 °C for 24 h.24 The reaction resulted in the formation of a trace amount of azidobenzene 4a as the product. Interestingly, using trimethylsilyl azide as the cross-coupling partner, we were pleased to observe the formation of 4a in 84% yield (Scheme 3b). Furthermore, a range of electronically diverse aryl iodides were evaluated, yielding the desired products in good to excellent yields in nearly all cases (cf.4d, 4e and 4h). As compared to previously reported C–N cross-coupling reactions of iodoarenes with amines,20 the C(sp2)–N3 coupling requires an elevated temperature of 100 °C. This may be attributed to the strong binding of azide to the Au(III) center, which makes the reductive elimination difficult at lower temperatures.
Furthermore, we investigated the reactivity of Au(III)–azide complexes towards ligand exchange reactions utilizing complex 3b as the model substrate (Scheme 4).10,11 Delightfully, complex 3b reacted efficiently with trimethylsilyl cyanide at room temperature to afford 4-fluorobenzonitrile 5 in 99% yield. Next, the reaction of 3b with ((4-methoxyphenyl)ethynyl)trimethylsilane delivered the C(sp2)–C(sp) cross-coupled product 6 in 87% yield. Interestingly, methyl propiolate could also be used as a cross-coupling partner to obtain the product 7 in 96% yield. Taken together, the work highlights the stable yet reactive nature of Au(III)–azide complexes, making them valuable intermediates in organic synthesis.
 |
| Scheme 4 Reactivity of (P^N) aryl Au(III)–azide complex towards ligand exchange and reductive elimination processes.a (a) Reaction with TMSCN. Conditions: 0.20 mmol 3b, 1.0 mmol TMSCN, DCM (0.1 M), rt, 20 min. (b) Reaction with TMS-alkyne. Conditions: 0.20 mmol 3b, 1.0 mmol TMS-alkyne, DCM (0.1 M), 60 °C, 48 h. (c) Reaction with terminal alkyne. Conditions: 0.20 mmol 3b, 1.0 mmol methyl propiolate, DCM (0.1 M), 60 °C, 24 h. a Isolated yields. | |
In conclusion, the synthesis of (P^N) aryl gold(III)–azide complexes has been successfully achieved. The MeDalPhos-ligated Au(III)-azide complexes, featuring a broad range of electronically diverse aryl groups, demonstrate high stability, facilitating their isolation and characterization. The gold(III)–azide complexes readily undergo C(sp2)–N3 reductive elimination under thermal conditions, a finding that has enabled the development of a catalytic aryl-N3 cross-coupling reaction. Furthermore, we showed that the Au(III)–azide complex undergoes ligand exchange with various C(sp) nucleophiles leading to C(sp2)–C(sp) cross-coupling products.
Generous financial support by Anusandhan National Research Foundation (ANRF), India, via research grants (CRG/2022/000195, SCP/2022/000063 and JCB/2022/000052) is acknowledged. Urvashi thanks Ministry of Education, Government of India for PMRF. We acknowledge Dr Chandan Nandi for solving the X-ray crystal structure data. The authors would also like to thank the Department of Science and Technology (India) for awarding the DST-FIST grant (SR/FST/CS-II/2023/312) to support NMR facilities at IISER Bhopal.
Data availability
The data supporting this article, including synthetic procedures, spectral data, and crystallographic data have been included as part of the ESI.† Crystallographic data have been deposited at the CCDC under identification number 2425771.†
Conflicts of interest
There are no conflicts to declare.
References
- Reviews:
(a) M. Joost, A. Amgoune and D. Bourissou, Angew. Chem., Int. Ed., 2015, 54, 15022–15045 CrossRef CAS PubMed;
(b) L. Rocchigiani and M. Bochmann, Chem. Rev., 2021, 121, 8364–8451 CrossRef CAS PubMed;
(c) A. T. Sedikides, R. C. Walters, A. C. Dean and A. J. J. Lennox, Angew. Chem., Int. Ed., 2025, e202424656 Search PubMed.
-
(a) B. Bertrand and A. Casini, Dalton Trans., 2014, 43, 4209–4219 RSC;
(b) T. Zou, C. T. Lum, C.-N. Lok, J.-J. Zhang and C.-M. Che, Chem. Soc. Rev., 2015, 44, 8786–8801 RSC;
(c) B. Bertrand, M. R. M. Williams and M. Bochmann, Chem. – Eur. J., 2018, 24, 11840–11851 CrossRef CAS PubMed.
-
(a) V. W.-W. Yam and A. S.-Y. Law, Coord. Chem. Rev., 2020, 414, 213298 CrossRef CAS;
(b) W.-P. To, Q. Wan, G. S. M. Tong and C.-M. Che, Trends Chem., 2020, 2, 796–812 CrossRef CAS;
(c) M.-C. Tang, M.-Y. Chan and V. W.-W. Yam, Chem. Rev., 2021, 121, 7249–7279 CrossRef CAS PubMed.
- S. G. Bratsch, J. Phys. Chem. Ref. Data, 1989, 18, 1–21 CrossRef CAS.
- Review: R. Kumar and C. Nevado, Angew. Chem., Int. Ed., 2017, 56, 1994–2015 CrossRef CAS PubMed.
- Reviews and accounts:
(a)
W. Henderson, The Chemistry of Cyclometallated Gold(III) Complexes with C,N−Donor Ligands. in Adv. Organomet. Chem., ed., R. West and A. F. Hill, Academic Press, New York, 2006, vol. 54, pp. 207−265 Search PubMed;
(b) M. S. M. Holmsen, A. Nova and M. Tilset, Acc. Chem. Res., 2023, 56, 3654–3664 CrossRef CAS PubMed Selected reports: ;
(c) Q. Wu, C. Du, Y. Huang, X. Liu, Z. Long, F. Song and J. You, Chem. Sci., 2015, 6, 288–293 RSC;
(d) F.-F. Hung, W.-P. To, J.-J. Zhang, C. Ma, W.-Y. Wong and C.-M. Che, Chem. – Eur. J., 2014, 20, 8604–8614 CrossRef CAS PubMed;
(e) R. Kumar, A. Linden and C. Nevado, J. Am. Chem. Soc., 2016, 138, 13790–13793 CrossRef CAS PubMed;
(f) K. Tsubokura, K. K. H. Vong, A. R. Pradipta, A. Ogura, S. Urano, T. Tahara, S. Nozaki, H. Onoe, Y. Nakao, R. Sibgatullina, A. Kurbangalieva, Y. Watanabe and K. Tanaka, Angew. Chem., Int. Ed., 2017, 56, 3579–3584 CrossRef CAS PubMed;
(g) B. Y.-W. Wong, H.-L. Wong, Y.-C. Wong, V. K.-M. Au, M.-Y. Chan and V. W.-W. Yam, Chem. Sci., 2017, 8, 6936–6946 RSC;
(h) M. Bachmann, J. Terreni, O. Blacque and K. Venkatesan, Chem. – Eur. J., 2017, 23, 3837–3849 CrossRef CAS PubMed;
(i) J.-F. Cui, H.-M. Ko, K.-P. Shing, J.-R. Deng, N. C.-H. Lai and M.-K. Wong, Angew. Chem., Int. Ed., 2017, 56, 3074–3079 CrossRef CAS PubMed;
(j) S. M. Holmsen, A. Nova, D. Balcells, E. Langseth, S. Øien-Ødegaard, R. H. Heyn, M. Tilset and G. Laurenczy, ACS Catal., 2017, 7, 5023–5034 CrossRef;
(k) J. A. González, F. Verdugo, J. L. Mascareñas, F. López and C. Nevado, Angew. Chem., Int. Ed., 2020, 59, 20049–20054 CrossRef PubMed;
(l) R. Bonsignore, S. R. Thomas, M. Rigoulet, C. Jandl, A. Pöthig, D. Bourissou, G. Barone and A. Casini, Chem. – Eur. J., 2021, 27, 14322–14334 CrossRef CAS PubMed;
(m) J. Martín, E. Gómez-Bengoa, A. Genoux and C. Nevado, Angew. Chem., Int. Ed., 2022, 61, e202116755 CrossRef PubMed.
- Reviews:
(a) B. Huang, M. Hu and F. D. Toste, Trends Chem., 2020, 2, 707–720 CrossRef CAS PubMed;
(b) V. W. Bhoyare, A. G. Tathe, A. Das, C. C. Chintawar and N. T. Patil, Chem. Soc. Rev., 2021, 50, 10422–10450 RSC;
(c) P. Font and X. Ribas, Eur. J. Inorg. Chem., 2021, 2556–2569 CrossRef CAS;
(d) S. B. Ambegave and N. T. Patil, Synlett, 2023, 698–708 CAS;
(e) P. Font, H. Valdés and X. Ribas, Angew. Chem., Int. Ed., 2024, 63, e202405824 CrossRef CAS PubMed.
- M. Messina, J. M. Stauber, M. A. Waddington, A. L. Rheingold, H. D. Maynard and A. M. Spokoyny, J. Am. Chem. Soc., 2018, 140, 7065–7069 CrossRef CAS PubMed.
- E. A. Doud, J. A. R. Tilden, J. W. Treacy, E. Y. Chao, H. R. Montgomery, G. E. Kunkel, E. J. Olivares, N. Adhami, T. A. Kerr, Y. Chen, A. L. Rheingold, J. A. Loo, C. G. Frost, K. N. Houk, H. D. Maynard and A. M. Spokoyny, J. Am. Chem. Soc., 2024, 146, 12365–12374 CrossRef CAS PubMed.
- A. Genoux, M. Biedrzycki, E. Merino, E. Rivera-Chao, A. Linden and C. Nevado, Angew. Chem., Int. Ed., 2021, 60, 4164–4168 CrossRef CAS PubMed.
- D. Vesseur, S. Li, S. Mallet-Ladeira, K. Miqueu and D. Bourissou, J. Am. Chem. Soc., 2024, 146, 11352–11363 CAS.
-
(a) M. Joost, A. Zeineddine, L. Estévez, S. Mallet−Ladeira, K. Miqueu, A. Amgoune and D. Bourissou, J. Am. Chem. Soc., 2014, 136, 14654–14657 CrossRef CAS PubMed;
(b) A. Zeineddine, L. Estévez, S. Mallet-Ladeira, K. Miqueu, A. Amgoune and D. Bourissou, Nat. Commun., 2017, 8, 565 CrossRef PubMed;
(c) M. J. Harper, C. J. Arthur, J. Crosby, E. J. Emmett, R. L. Falconer, A. J. Fensham-Smith, P. J. Gates, T. Leman, J. E. McGrady, J. F. Bower and C. A. Russell, J. Am. Chem. Soc., 2018, 140, 4440–4445 CrossRef CAS PubMed;
(d) P. Font, H. Valdés, G. Guisado-Barrios and X. Ribas, Chem. Sci., 2022, 13, 9351–9360 RSC;
(e) P. Gao, J. Xu, T. Zhou, Y. Liu, E. Bisz, B. Dziuk, R. Lalancette, R. Szostak, D. Zhang and M. Szostak, Angew. Chem., Int. Ed., 2023, 62, e202218427 CrossRef CAS PubMed;
(f) S. C. Scott, J. A. Cadge, G. K. Boden, J. F. Bower and C. A. Russell, Angew. Chem., Int. Ed., 2023, 62, e202301526 CrossRef CAS PubMed;
(g) K. Muratov, E. Zaripov, M. V. Berezovski and F. Gagosz, J. Am. Chem. Soc., 2024, 146, 3660–3674 CrossRef CAS PubMed.
- R. Uson, A. Laguna and J. L. Sanjoaquin, J. Organomet. Chem., 1974, 80, 147–154 CrossRef CAS.
- T. Roth, H. Wadepohl and L. H. Gade, Eur. J. Inorg. Chem., 2016, 1184–1191 CrossRef CAS.
- A. Pérez-Bitrián, S. Alvarez, M. Baya, J. Echeverría, A. Martín, J. Orduna and B. Menjón, Chem. – Eur. J., 2023, 29, e202203181 CrossRef PubMed.
- M. Winter, M. A. Ellwanger, N. Limberg, A. Pérez-Bitrián, P. Voßnacker, S. Steinhauer and S. Riedel, Chem. – Eur. J., 2023, 29, e202301684 CrossRef CAS PubMed.
- D. Moreth, G. Hörner, V. V. L. Muller, L. Geyer and U. Schatzschneider, Inorg. Chem., 2023, 62, 16000–16012 CrossRef CAS PubMed.
-
(a) H. H. Schmidtke and D. Garthoff, J. Am. Chem. Soc., 1967, 89, 1317–1321 CrossRef CAS;
(b) T. M. Klapötke, B. Krumm, J.-C. Galvez-Ruiz and H. Nöth, Inorg. Chem., 2005, 44, 9625–9627 CrossRef PubMed;
(c) E. Schuh, S. Werner, D. Otte, U. Monkowius and F. Mohr, Organometallics, 2016, 35, 3448–3451 CrossRef CAS;
(d) K. Peng, A. Friedrich and U. Schatzschneider, Chem. Commun., 2019, 55, 8142–8145 RSC;
(e) V. Levchenko, S. Øien-Ødegaard, D. Wragg and M. Tilset, Acta Cryst., 2020, 76, 1725–1727 CAS.
-
(a) J. Rodriguez, D. Vesseur, A. Tabey, S. Mallet-Ladeira, K. Miqueu and D. Bourissou, ACS Catal., 2022, 12, 993–1003 CrossRef CAS;
(b) V. W. Bhoyare, E. D. Sosa Carrizo, C. C. Chintawar, V. Gandon and N. T. Patil, J. Am. Chem. Soc., 2023, 145, 8810–8816 CrossRef CAS PubMed;
(c) C. Wei, L. Zhang and Z. Xia, Org. Lett., 2023, 25, 6808–6812 CrossRef CAS PubMed;
(d) V. W. Bhoyare, A. G. Tathe, V. Gandon and N. T. Patil, Angew. Chem., Int. Ed., 2023, 62, e202312786 CrossRef CAS PubMed;
(e) V. W. Bhoyare, A. Bera, V. Gandon and N. T. Patil, Angew. Chem., Int. Ed., 2024, e202410794 CAS;
(f) A. Kumar, N. Bhattacharya, M. V. Mane and N. T. Patil, Angew. Chem., Int. Ed., 2024, e202412682 CAS;
(g) W. Du, F. Zhao, R. Yang and Z. Xia, Org. Lett., 2024, 26, 3145–3150 CrossRef CAS PubMed.
-
(a) M. O. Akram, A. Das, I. Chakrabarty and N. T. Patil, Org. Lett., 2019, 21, 8101–8105 CrossRef CAS PubMed;
(b) J. Rodriguez, N. Adet, N. Saffon-Merceron and D. Bourissou, Chem. Commun., 2020, 56, 94–97 RSC;
(c) W. Li, Y. Chen, Y. Chen, S. Xia, W. Chang, C. Zhu, K. N. Houk, Y. Liang and J. Xie, J. Am. Chem. Soc., 2023, 145, 14865–14873 CrossRef CAS PubMed;
(d) Urvashi, S. Rai, G. Shukla, Nisha and N. T. Patil, Org. Lett., 2025, 27, 2364–2370 CrossRef CAS PubMed.
-
(a) A. Das and N. T. Patil, ACS Catal., 2023, 13, 3847–3853 CrossRef CAS;
(b) G. Chen and B. Xu, ACS Catal., 2023, 13, 1823–1829 CrossRef CAS.
-
(a) S. R. Mudshinge, Y. Yang, B. Xu, G. B. Hammond and Z. Lu, Angew. Chem., Int. Ed., 2022, 61, e202115687 CrossRef CAS PubMed;
(b) A. G. Tathe and N. T. Patil, Org. Lett., 2022, 24, 4459–4463 CrossRef CAS PubMed;
(c) Urvashi, S. Mishra and N. T. Patil, Chem. Sci., 2023, 14, 13134–13139 RSC;
(d) L. Zhang, W. Du, J. Wu, R. Yang, X.-T.-F. E, J. Wang and Z. Xia, Org. Lett., 2024, 26, 9413–9418 CrossRef CAS PubMed.
- Review: M. Goswami and B. de Bruin, Eur. J. Org. Chem., 2017, 1152–1176 CrossRef CAS PubMed.
- See the ESI†.
|
This journal is © The Royal Society of Chemistry 2025 |
Click here to see how this site uses Cookies. View our privacy policy here.